The online conference will discuss how high-level research environments on life science and healthcare work in Catalonia and Sweden amid the current COVID-19 pandemic and how they answer to the need for a fast and high-quality scientific response.
Sweden and Catalonia are known for high-quality research environments, being their capital cities in the 10th and 12th ranking position with regards to scientific publications in the EU, especially in the life science and healthcare sector. Both are known to have robust indicators and long-term strategies in R+D+I, and high-level scientific facilities in BioTech and MedTech, among others. They are ranked 4th and 5th as technology hubs in investment in Europe, according to Dealroom.
The discussion will highlight how cooperation between academia, public and private sectors is a key factor to deliver a positive final social impact. It will also stress the commitment to fostering the Sustainable Development Goals (SDGs) number 3 and 9 for good health and well-being, resilient infrastructures and inclusive and sustainable industrialization and innovation.
Finally, this debate will take place as the Catalan public broadcaster –TV3 and Catalunya Ràdio– organizes its annual charity La Marató which this year will focus on the new coronavirus SARS-CoV-2. Since its first edition in 1992, La Marató has raised a total of 202 M€ and provided financial support to 872 research projects involving 8.000 research organizations. Catalans engage every year in this crowdfunding event, including in this edition Catalan communities abroad like those in the Nordic countries.
The discussion will bring together renowned experts such as Björn Arvidsson, Managing Director of Uppsala STUNS Life science; Jordi Naval, General Director of Catalan life science Biocat, (BioRegion Catalonia); Mia Ekdahl, Head of Communications of the Sahlgrenska Science Park Life science of West Sweden, and Núria Montserrat, stem cell biologist and ICREA Professor at the Institute for Bioengineering of Catalonia (IBEC).
The debate will be moderated by Mikolaj Norek – Uppsala STUNS.
This Conference will be broadcasted online. Kindly register here to participate.
Björn Arvidsson, Managing Director of Uppsala STUNS Life science. M.Sc Ph.D (Uppsala University). Arvidsson had different roles in Roche Diagnostics and Roche pharmaceutical, in product management among others.
Jordi Naval, General Director of Catalan life science Biocat (BioRegion Catalonia). Co-founder of AELIX Therapeutics, developing new therapies for HIV. He had a previous position in tech transfer (University of Barcelona).
Mia Ekdahl, Head of Communications, Sahlgrenska Science Park Life science. She had different positions in AstraZeneca’s Global Corporate Affairs. She also led a communications consultancy supporting life science entrepreneurs.
Núria Montserrat, stem cell biologist and ICREA Professor at the Institute for Bioengineering of Catalonia (IBEC). Senior group leader in IBEC, leading expert in organ regeneration focused now on understanding SARS-CoV-2.